Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?
Here is how Delcath Systems, Inc. (DCTH) and Encompass Health (EHC) have performed compared to their sector so far this year.
Zacks Investment Research9/15/2026Negative
DCTH
Delcath Systems IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$541.30M
P/E Ratio
1560.00
EPS
$0.01
Beta
0.57
52W High
$17.42
52W Low
$8.12
50-Day MA
$15.23
200-Day MA
$11.71
Dividend Yield
—
Profit Margin
0.56%
Forward P/E
232.56
PEG Ratio
1.60
About Delcath Systems Inc
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $95.42M |
| Gross Profit (TTM) | $83.06M |
| EBITDA | $-1.46M |
| Operating Margin | 8.22% |
| Return on Equity | 0.47% |
| Return on Assets | -0.89% |
| Revenue/Share (TTM) | $2.64 |
| Book Value | $3.50 |
| Price-to-Book | 4.70 |
| Price-to-Sales (TTM) | 5.67 |
| EV/Revenue | 4.825 |
| EV/EBITDA | 294.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 20.60% |
| Shares Outstanding | $34.70M |
| Float | $28.78M |
| % Insiders | 8.09% |
| % Institutions | 51.78% |
Historical Volatility
HV 10-Day
30.99%
HV 20-Day
24.15%
HV 30-Day
27.92%
HV 60-Day
57.48%
HV Rank
1.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($24.00 target)
1
Strong Buy4
BuyLatest News
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company's Compensation Committee, as material inducements to four individuals whose employment commenced in either July 2026 or August 2026. The grants, in the form of Restricted Stock Units (RSUs), totaled 34,00.
Business Wire9/11/2026Neutral
Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH
VLO, PBF, FET and DCTH screen as low-beta picks as volatility rises, backed by refining, energy-equipment and liver-cancer growth drivers.
Zacks Investment Research9/8/2026Neutral
5 Stocks With Recent Price Strength Buoyed by a Strong August
EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.
Zacks Investment Research9/4/2026Positive
What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research8/28/2026Positive
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks Investment Research8/28/2026Positive
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 52.4% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Investment Research8/27/2026Positive
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks Investment Research8/12/2026Positive
Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research8/11/2026Positive
Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Investment Research8/11/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DCTH and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/28/2026